You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -37,310.2% | -377.1% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -2.7 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 795.8 | 7.9 |
| Price / Book value | 1.7 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 14.0% | 852.4% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | -38.8% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2015-03-31 | 0.03 | -10.30 | -50.00p | -7.3 | 0.0 | n/a | n/a | 0.0% |
| 2016-03-31 | 0.03 | -12.85 | -40.00p | -8.4 | 0.0 | n/a | n/a | 0.0% |
| 2017-03-31 | 0.05 | -18.16 | -4,920.00p | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2018-03-31 | 0.04 | -20.97 | -55.70p | -1.5 | 0.0 | n/a | n/a | 0.0% |
| 2019-03-31 | 0.05 | -17.18 | -45.20p | -2.3 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | 4.97 | -18.73 | -46.22p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2021-03-31 | 3.04 | -22.20 | -49.22p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| ReNeuron presents new data on CTX stem cell platform Sharecast News | 23 Oct |
|---|---|
| ReNeuron boosts scientific advisory board with three appointments Sharecast News | 21 Aug |
| ReNeuron enters grant-funded partnership with University of Cardiff Sharecast News | 14 Aug |
| ReNeuron's lead cell line shows further potential | 23-Oct-19 07:03 |
|---|---|
| Notification of Major Holdings | 17-Oct-19 17:38 |
| Notification of Major Holdings | 17-Oct-19 15:22 |
| Positive clinical data presented at AAO meeting | 14-Oct-19 07:04 |
| Second Price Monitoring Extn | 02-Oct-19 16:41 |